Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation
Cell Reports · 2026-11 · 45 (11) · 118301
DOI: 10.1016/j.celrep.2026.118301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-11. Verfasst von Carlos M Soto-Faguás und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Oregon Health & Science University, Portland, OR, USA; Jungers Center for Neurosciences Research, Oregon Health & Science Un…. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: American Parkinson Disease Association.
Abstract (Originalsprache)
Apolipoprotein E (APOE) genotype alters the risk for Alzheimer's disease (AD) but also affects dementia risk in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Recent evidence suggests that the APOE Christchurch (CC) mutation protects against AD, however, its effects on PD and DLB are unknown. We generated an APOE CC knock-in mouse to understand its effects on amyloid-β (Aβ), tau, and α-synuclein (α-syn) aggregation. APOE CC mice show increased plasma cholesterol and triglyceride levels, decreased Aβ and Aβ-induced tau pathology after intracortical AD-tau injection into 5xFAD mice but do not change Aβ or tau pathology in individual transgenic mouse models without injection. Interestingly, APOE CC reduces formation and spread of α-syn aggregation in the brain, peripheral-to-spinal cord spread, and directly increases binding affinity to α-syn compared to APOE WT. Our study emphasizes the remarkable protective effects of a point mutation in murine APOE against Aβ-induced tau and α-syn aggregation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Oregon Health & Science University, Portland, OR, USA; Jungers Center for Neurosciences Research, Oregon Health & Science University, Portland, OR, USA. Electronic address: sotofagu@ohsu.edu.
- Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, USA.
- Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
- Independent Researcher, Portland, OR, USA.
- OHSU Transgenic Mouse Models Core Lab, Oregon Health & Science University, Portland, OR, USA.
- Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA.
Förderung
- American Parkinson Disease Association
Zitieren
APA
Soto-Faguás, C. M., O'Niel, A., Saltonstall, E., Mueller, P. A., Sanchez-Molina, P., Fedorov, L. M., Woltjer, R. L., Raber, J., & Unni, V. K. (2026). Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation. Cell Reports, 45(11), 118301. https://doi.org/10.1016/j.celrep.2026.118301
Vancouver
Soto-Faguás CM, O'Niel A, Saltonstall E, Mueller PA, Sanchez-Molina P, Fedorov LM, et al. Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation. Cell Reports. 2026;45(11):118301. doi:10.1016/j.celrep.2026.118301
BibTeX
@article{SotoFagus2026,
author = {Soto-Faguás, Carlos M and O'Niel, Abigail and Saltonstall, Elizabeth and Mueller, Paul A and Sanchez-Molina, Paula and Fedorov, Lev M and Woltjer, Randall L and Raber, Jacob and Unni, Vivek K},
title = {Mouse APOE Christchurch protects against Aβ-induced tau and α-synuclein aggregation},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {11},
pages = {118301},
doi = {10.1016/j.celrep.2026.118301}
}
EUVIMED